Statistics from Altmetric.com
The Lancet series of papers on low back pain (LBP)1–3 received considerable academic and media attention, and helpfully reinforced key messages from international guidelines. Box 1 highlights some of the series’ key messages. The series illustrated international, multidisciplinary consensus on management of LBP. The series provides the reader with a comprehensive review of the most promising solutions, ranging from stratified care according to clinical risk profiling, through integrated health and occupational care, changes to payment systems and legislation, as well as public health and prevention strategies. This is important as all too often, guidelines and systematic reviews focus on the effectiveness, or lack thereof, of particular treatment options in isolation, without considering the broader context within which treatments are delivered. Here, we reflect on three issues from the series and discuss the clinical implications.
Lessons from the Lancet low back series
Low back pain (LBP) is a major global challenge, and back-related disability is increasing.
The majority of LBP is not serious and cannot be linked to a specific structure.
Most red flags have limited diagnostic accuracy.
Imaging use is often inappropriate for non-specific LBP.
Non-pharmacological treatments such as advice and activity should be first-line options in the treatment of non-specific LBP.
Opioids have small effects, but have …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.